Monitoring Diabetic Control in Developing Countries: A Review of Glycated Haemoglobin and Fructosamine Assays

Tropical Doctor

Volumn 28, Issue 1, 1998, Pages 9-15

  Rahlenbeck, Sibylle I ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLYCOSYLATED HEMOGLOBIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; COST CONTROL; DEVELOPING COUNTRY; DIABETES CONTROL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS;

ADULT; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CHROMATOGRAPHY; DEVELOPING COUNTRIES; DIABETES MELLITUS; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOASSAY;

EID: 0031914024     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947559802800105     Document Type: Review

References (60)

1. King H, Rewers M. Diabetes in adults is now a third world problem: The WHO Ad Hoc Diabetes Reporting Group. Bull World Health Organ, 1991; 69: 643-8
2. McLarty DG, Politt C, Swai AB. Diabetes in Africa. Diabet Med., 1990; 7: 670-84
3. Rolfe M. Diabetic renal disease in Central Africa. Diabet Med., 1988; 5: 630-3
4. McLarty DG, Kinabo L, Swai AB. Diabetes in tropical Africa: a prospective study 1981-87. Course and prognosis. BMJ, 1990; 300: 1107-10
5. Lester F. Clinical status in Ethiopian diabetic patients after 20 years of diabetes. Diabet Med., 1991; 8: 272-6
6. Kalk WJ, Osier CE, Taylor D, Panz VR. Prior long-term glycaemic control and insulin therapy in insulin-dependent diabetic adolescent with microalbuminaria. Diabet Res Clin Pract, 1990; 9: 83-8
7. Akanji AO, Agbedana AO, Ogbode C. Plasma lipid profiles in relation to diabetic control in Nigerians. Afr J Med Med Sci., 1989; 18: 229-34
8. Atabani GS, Saaed BO, Al-Mahdi EM, Adam ME, Hassan DA. Glycated haemoglobin and other biochemical parameters in Sudanese diabetics. Ann Clin Biochem, 1989; 26: 32-4
9. Famuyiwa OO, Abanji AO, Bella AF. Haemoglobin A, levels in Nigerian diabetic patients using microcolumn affinity chromatography. Afr J Med Med Sci., 1986; 15: 49-53
10. Gebre-Yohannes A, Rahlenbeck SI. Glycaemic control and its determinants in diabetic patients in Ethiopia. Diabet Res Clin Pract, 1997; 35: 129-34
11. Reiber GE, King H. Guidelines for the development of a national program for diabetes mellitus. Geneva: World Health Organization: 1991
12. Atabani GS, Al-Whali NM, Saeed BO, Al-Mahdi MA. Effect of 75 g oral glucose on fructosamine and glycated haemoglobin concentrations. Ann Clin Biochem, 1990; 27: 270-1
13. Rao GM, Morghom LO, Abukhris AA, Mansori SS, Ragale LY. Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients. Trop Geogr Med., 1986; 38: 391-7
14. Prendergast C, Smyth O, Murray F, Cunningham SK, McKenna TJ. The relationship of blood glucose and haemoglobin A1 levels in diabetic subjects. Ir J Med Sci., 1994; 163: 233-5
15. Nathan JM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of glycosylated hemoglobin assay. New Engl J Med., 1984; 310: 341-6
16. Bunn HG, Gabbay KH, Galopp PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science, 1978; 200: 21-7
17. Little RR, Wiedmeyer HM, England JD, Naito HK, Goldstein DE. Interlaboratory comparison of glycohemoglobin results: College of American Pathologists survey data. Clin Chem, 1991; 37: 1725-9
18. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose levels. Diabetes Care, 1995; 18: 440-7
19. James TM, Davis JE, McDonald JM, Santiago JV, Ladensen JH. Comparison of hemoglobin A1c and hemoglobin A1 in diabetic patients. Clin Biochem, 1981; 14: 25-7
20. Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM. Glycated hemoglobin: methodologies and clinical applications. Clin Chem. 1986; 32: 64-70
21. Little RR, England JD, Wiedmeyer HM, Goldstein DE. Effects of whole blood storage on results for glycosylated hemoglobin as measured by ion-exchange chromatography, affinity chromatography and colorimetry. Clin Chem, 1983; 29: 1113-15
22. Mortensen HB, Nielsen L, Soegaard U, Svendsen PA, Nerup J. Comparison of six assays for glycated haemoglobin determination. Scand J Clin Lab Invest, 1993; 43: 357-62
23. Bodor GS, Little RR, Garett N, Brown W, Goldstein DE, Nahm MH. Standardization of glycohemoglobin determinations in the clinical laboratory. Clin Chem, 1992; 38: 2414-18
24. Weykamp CW, Penders TJ, Muskiet FA, van der Silk W. Glycohaemoglobin: a comparison of 12 analytical methods, applied to lyophilized haemolysates by 101 laboratories in an external quality assurance programme. Ann Clin Biochem, 1993; 30: 169-174
25. John WG. Glycated haemoglobin analysis. Ann Clin Chem Biochem, 1997; 34: 17-31
26. c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia. Clin Chem, 1989; 35: 93-7
27. Miedema K. Influence of hemoglobin variants on the determination of glycated hemoglobins. Clin Lab, 1993; 39: 1029-32
28. 1c determinations using Bio-Rad columns. Clin Chem, 1985; 18: 173-5
29. Reid HL, Famodu AA, Photiades OP, Osamo ON. Glycated haemoglobin HbAlc and HbSc in non-diabetic Nigerians. Trop Geogr Med., 1992; 44: 126-30
30. Kilpatrick ES, Rumley AG, Dominiczak MH, Small K. Glycated hemoglobin values: problems in assessing glucose control in diabetes mellitus. BMJ, 1994; 309: 983-6
31. 1c. Clin Chem, 1993; 39: 663-6
32. 1c using pre-calibrated unitized reagent cartridges. Clin Chem, 1992; 38: 234-45
33. 1c analyzer. Diabet Med., 1993; 10: 976-9
34. Eaton SE, Felden SE, Huisman P. Glycated haemoglobin (HbAlc) measurements in subjects with haemoglobin variants, using the DCA 2000. Ann Clin Biochem, 1997; 34: 205-7
35. Turpeinen U, Karjaleinen U, Stenman UH. Three assays for glycohemoglobin compared. Clin Chem, 1995; 41: 191-5
36. Campagnucci P, Cartechini MG, Bolli G, de Feo P, Santeus F, Brunetti P. The importance of determining irreversibly glycosylated hemoglobin in diabetics. Diabetes, 1981; 30: 607-17
37. Gomo ZA. The determination of glucose and glycosylated haemoglobins in a non-diabetic Zimbabwean African population. Ann Clin Biochem, 1985; 22: 362-5
38. 1c in evaluation of diabetic control in Kenya Africans. East Afr Med J, 1983; 60: 60-3
39. Mengistu M. The use of haemoglobin A1 in the evaluation of diabetic control in adult Ethiopian diabetics. Ethiop Med J, 1988; 26: 127-31
40. 1) for diabetic control in Africans: preliminary findings with the microcolumn technique. Trop Geogr Med., 1983; 35: 347-51
41. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development on long-term complications in insulin-dependent diabetes mellitus. New Eng J Med., 1993; 329: 977-86
42. Klein R, Klein BE, Moss SE, Cruickshanks K. Relationship of hyperglycaemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med., 1994; 154: 2169-78
43. Gilbert RE, Tsalamandris C, Bach LA et al., Long-term control and the rate of progression of early diabetes kidney disease. Kidney Int., 1993; 44: 855-9
44. Alberti KG, Gries FA. Management of non-insulin dependent diabetes mellitus in Europe: a consensus view. Diabet Med., 1988; 5: 275-81
45. European IDDM Policy Group. Consensus guidelines for the management of insulin-dependent (type 1) diabetes. Diabet Med., 1993; 10: 990-1005
46. Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycaemia in the Diabetes Control and Complications Trial. Am J Med., 1991; 90: 450-9
47. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem, 1987; 33: 21-63
48. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycoprotein. An index of diabetic control. Clin Chem, 1983; 127: 87-95
49. Mosca A, Carenini A, Zoppi F et al., Plasma protein glycation as measured by fructosamine assay. Clin Chem, 1987; 33: 1141-6
50. Jury DR, Dunn P. Laboratory assessment of a commercial kit for measuring fructosamine in serum. Clin Chem, 1987; 33: 158-61
51. Rodriguez-Segade S, Lojo S, Camina MF, Paz M, Del Rio R. Effects of various serum proteins on quantification of fructosamine. Clin Chem, 1989; 35: 134-8
52. Henny J, Schiele F. Age-dependence, sex-dependence, and reference values of serum fructosamine determined by a new colorimetric method. Wien Klin Wschr, 1990; 102 (suppl): S47–s51
53. Gomo ZA. Serum fructosamine: a parameter for monitoring control in diabetes. Centr Afr Med J, 1992; 38: 358-61
54. Singh J, Kulig KA. Effects of albumin and immunoglobulin A on fructosamine assay. Clin Chem, 1992; 38: 824-30
55. Baker JR, Metcalf PA, Holdaway AM, Johnson RN. Serum fructosamine concentration as a measure of blood glucose in type I diabetes mellitus. BMJ, 1985; 290: 352-5
56. Hindle EJ, Rostron GM, Gatt JA. The estimation of serum fructosamine: an alternative measurement to glycated haemoglobin. Ann Clin Biochem, 1985; 22: 84-9
57. Swai AB, Harrison K, Chuwa LM, Makene W, McCarty D, Alberti KG. Screening for diabetes. Does measurement of serum fructosamine help?. Diabet Med., 1988; 5: 648-52
58. Elwali NM Saeed BO, Atabani GS, Elmahdi EM, Mukhtar E. The use of plasma fructosamine in the assessment of diabetic control. Trop Geogr Med., 1991; 43: 51-4
59. Baker JR, Johnson RN, Scott DJ. Serum fructosamine concentrations in patients with type II diabetes mellitus during changes in management. BMJ, 1984; 288: 1484-6
60. Lloyd O, Marples J. Serum fructosamine and thyroid function. Clin Chem, 1986; 32: 1985-9